A series of quaternary dervatives of diethylaminoacetic acid ortho-toluidide have been synthesized by reactions with various halogen-containing derivatives of alkanes, alkenes, and arylalkanes in acetone. The acute toxicity and antiarrhythmic activity of the synthesized compounds have been studied. Several compounds with antiarrhythmic activity exceeding that of a structural analog (lidocaine) are found and recommended for further investigation and practical implementation.A compound called monomecaine with lower toxicity and greater antiarrhythmic activity than lidocaine has been discovered among derivatives of diethylaminoacetic acid arylamides [1 -3]. The therapeutic effect of lidocaine and its analog trimecaine (monomecaine belongs to this series) is known to be short-lived because of rapid destruction in the liver [4]. Further research showed that preparation of quaternary ammonium derivatives based on the aforementioned local anesthetics increases the effectiveness and duration of their antiarrhythmic action [5 -8].Diethylaminoacetic acid o-toluidide [9] and quaternary derivatives (QD) based on it were synthesized as before [4] in order to investigate their antiarrhythmic activity. Alkylation of diethylaminoacetic acid o-toluidide by various halogen-containing normal alkanes, alkenes, and arylalkanes by heating in acetone produced its QD. The reaction time was monitored by precipitation of the corresponding QD. Table 1 lists the structures of the products, yields, reaction times, physical constants, and PMR spectra.
EXPERIMENTAL CHEMICAL PART
Preparation of QD of diethylaminoacetic acid o-toluidide.A solution of diethylaminoacetic acid o-toluidide (0.04 mol) in acetone (30 mL) was heated with an equimolar amount (0.04 mol) of alkylhalide for 25 -95 h at 70 -110°C. The resulting salt crystallized from the reaction mixture or after cooling it. If the product was oily, it was washed with ether until the precipitate formed. Pure products were crystalline; soluble in water, ethanol, DMF, and CH 3 CN; and insoluble in diethylether, hexane, toluene, and acetone.Preparation of mineral salts of diethylaminoacetic acid o-toluidide. A solution of diethylaminoacetic acid o-toluidide (0.04 mol) in alcohol (10 mL) was heated with an equimolar amount of mineral acid for 2 -3 h. Evaporation of solvent produced a precipitate that was washed with alcohol and dried. Pure products were crystalline; soluble in water, ethanol, and DMF; and insoluble in diethylether, hexane, and acetone.
EXPERIMENTAL PHARMACOLOGICAL PARTTests were performed using white mice (18 -24 g). Antiarrhythmic activity was studied using an arrhythmia model induced by i.v. administration of CaCl 2 solution (3%, 280 mg/kg). Test compounds were administered i.v. 2 min after the appearance of arrhythmia. The activity was esti-665 0091-150X/08/4212-0665